Assessing seasonal influenza vaccine effectiveness

3 Dec 2014

On 3 December 2015, ECDC hosted a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.

The meeting was attended by representatives of public health and regulatory agencies on national and EU-level, the European Commission, Vaccines Europe, as well as representatives of the I-MOVE project partners and its coordinating partner Epiconcept

The aim of the meeting was to discuss the design of product-specific and vaccination programme-specific influenza vaccine effectiveness studies in the EU/EEA, and to explore what organisational models would be most useful to support such studies.